5 assets in Hypertriglyceridemia

Therapeutic assets addressing Hypertriglyceridemia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Tipelukast Hypertriglyceridemia	MediciNova	P2	B (57)
Tlc-2716 Hypertriglyceridemia	OrsoBio, Inc	P2	CCC (53)
rn0361 Hypertriglyceridemia	Ikaria Bioscience Pty Ltd	P1/2	CCC (48)
K-13675, (R)- Hypertriglyceridemia	Tokyo Women's Medical University	N/A	D (30)
Rdx-002 Hypertriglyceridemia	Response Pharmaceuticals	P2	NR ()